Cargando…
The telomeric PARP, tankyrases, as targets for cancer therapy
The requirement for the maintenance of telomeres by telomerase by most cancer cells for continued proliferation is a target in anticancer strategies. Tankyrases are poly(ADP-ribose) polymerases that enhance telomerase access to telomeres. Tankyrase 1 modulates telomerase inhibition in human cancer c...
Autor principal: | Seimiya, H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361147/ https://www.ncbi.nlm.nih.gov/pubmed/16421589 http://dx.doi.org/10.1038/sj.bjc.6602951 |
Ejemplares similares
-
De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy
por: Mashima, T, et al.
Publicado: (2009) -
Advances in using PARP inhibitors to treat cancer
por: Kummar, Shivaani, et al.
Publicado: (2012) -
The telomere protein tankyrase 1 regulates DNA damage responses at telomeres
por: Chang, Sandy
Publicado: (2010) -
Tankyrase: A new breed of telomere security guard
por: Williams, Ruth
Publicado: (2009) -
Insights into the binding of PARP inhibitors to the catalytic domain of human tankyrase-2
por: Qiu, Wei, et al.
Publicado: (2014)